Enveric Biosciences, Inc. (ENVB)

$1.52

+0.05 (+3.40%)
Rating:
Recommendation:
-
Symbol ENVB
Price $1.52
Beta 0.192
Volume Avg. 0.02M
Market Cap 3.528M
Shares () -
52 Week Range 1.3-6.98
1y Target Est -
DCF Unlevered ENVB DCF ->
DCF Levered ENVB LDCF ->
ROE -344.02% Strong Sell
ROA -420.82% Strong Sell
Operating Margin -
Debt / Equity -
P/E -0.13 Neutral
P/B 1.35 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ENVB news


Dr. Joseph Edward Tucker Ph.D.
Healthcare
Biotechnology
NASDAQ Capital Market

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.